| Revenue | SEK 3,2M | +12% |
| EBITDA | SEK 161K | +560% |
| Net profit | SEK 117K | +416% |
| Total assets | SEK 284K | -36% |
| Equity | SEK 124K | +1967% |
| Employees | 2 | — |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 348 | 2 951 | 2 741 | 2 875 | 3 216 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 85 | 13 | −53 | −35 | 161 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 85 | 13 | −53 | −35 | 161 |
| Net financials | — | — | 1 | −2 | −1 |
| Profit before tax | 64 | 34 | −52 | −37 | 160 |
| Tax | −13 | −14 | −0 | −0 | −43 |
| Net profit | 51 | 20 | −52 | −37 | 117 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 250 | 447 | 390 | 442 | 284 |
| Equity | 76 | 96 | 44 | 6 | 124 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 153 | 351 | 346 | 435 | 161 |
| Total debt | 153 | 351 | 346 | 435 | 161 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SJ | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (3) | ||
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
No shareholder data available.
| Person | Role here | Other companies |
|---|---|---|
| Sten Johan Pharmanson | Audit | 0 companies |
| Hans Jarl Rutger Arnhult | Deputy Board Member | 0 companies |
| Bo Daniel Falk | Deputy Board Member | 0 companies |
| Lars Anders Larsson | Board of Directors | 0 companies |
| Pooya Madjidi Bergström | Deputy Board Member | 0 companies |
| Homan Panahi | Board of Directors | 0 companies |